132 related articles for article (PubMed ID: 17606713)
1. Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma.
Elliott B; Scolyer RA; Suciu S; Lebecque S; Rimoldi D; Gugerli O; Musat E; Sharma RN; Lienard D; Keilholz U; Testori A; Eggermont A; MacKie R; Robert C; Cook M; Thompson JF; Angevin E; Spatz A;
Clin Cancer Res; 2007 Jul; 13(13):3825-30. PubMed ID: 17606713
[TBL] [Abstract][Full Text] [Related]
2. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
3. Presence of mature DC-Lamp+ dendritic cells in sentinel and non-sentinel lymph nodes of breast cancer patients.
Bembenek A; Li J; Loddenkemper C; Kemmner W; Stein H; Wernecke KD; Schlag PM
Eur J Surg Oncol; 2008 May; 34(5):514-8. PubMed ID: 17618075
[TBL] [Abstract][Full Text] [Related]
4. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
6. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience.
De Giorgi V; Leporatti G; Massi D; Lo Russo G; Sestini S; Dini M; Lotti T
Oncology; 2007; 73(5-6):401-6. PubMed ID: 18515980
[TBL] [Abstract][Full Text] [Related]
9. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.
Movassagh M; Spatz A; Davoust J; Lebecque S; Romero P; Pittet M; Rimoldi D; Liénard D; Gugerli O; Ferradini L; Robert C; Avril MF; Zitvogel L; Angevin E
Cancer Res; 2004 Mar; 64(6):2192-8. PubMed ID: 15026362
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
Lee JH; Torisu-Itakara H; Cochran AJ; Kadison A; Huynh Y; Morton DL; Essner R
Clin Cancer Res; 2005 Jan; 11(1):107-12. PubMed ID: 15671534
[TBL] [Abstract][Full Text] [Related]
11. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
12. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
Gutzmer R; Satzger I; Thoms KM; Völker B; Mitteldorf C; Kapp A; Bertsch HP; Kretschmer L
J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216
[TBL] [Abstract][Full Text] [Related]
14. An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma.
Schmidt CR; Panageas KS; Coit DG; Patel A; Brady MS
Ann Surg Oncol; 2009 Apr; 16(4):948-52. PubMed ID: 19194758
[TBL] [Abstract][Full Text] [Related]
15. Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer.
Sakakura K; Chikamatsu K; Sakurai T; Takahashi K; Murata T; Oriuchi N; Furuya N
Oral Oncol; 2005 Jan; 41(1):89-96. PubMed ID: 15598591
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
17. Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients.
Molenkamp BG; van Leeuwen PA; Meijer S; Sluijter BJ; Wijnands PG; Baars A; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2007 May; 13(10):2961-9. PubMed ID: 17504997
[TBL] [Abstract][Full Text] [Related]
18. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
20. Immune cell profile of sentinel lymph nodes in patients with malignant melanoma - FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome.
Mohos A; Sebestyén T; Liszkay G; Plótár V; Horváth S; Gaudi I; Ladányi A
J Transl Med; 2013 Feb; 11():43. PubMed ID: 23418928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]